SCHEMBL23635936

SCHEMBL23635936

COCc1ccc(OC)cc1-c1nnc(NC(=O)OC(C)(C)C)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.49
ALDH1A1 P00352 7/20 0.49
HPGD P15428 5/20 0.49
RXFP1 Q9HBX9 2/20 0.49
KDM4E B2RXH2 9/20 0.48
RAB9A P51151 7/20 0.48
KMT2A Q03164 4/20 0.48
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 6/20 0.47
HSD17B10 Q99714 5/20 0.46
USP2 O75604 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
MEN1 O00255 3/20 0.45
TP53 P04637 2/20 0.43
TSHR P16473 1/20 0.43
POLB P06746 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
LMNA P02545 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30842110 1.00 NPC1 (0.49) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL23292567 0.85 NPC1 (0.54) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL27097771 0.84 KDM4E (0.56) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL23635946 0.84 KDM4E (0.55) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL27097742 0.76 KDM4E (0.58) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL23635873 0.74 KDM4E (0.54) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL23292543 0.73 DYRK1A (0.41) NPC1ALDH1A1HPGDRXFP1KDM4E
SCHEMBL23292540 0.73 KDM4E (0.54) NPC1ALDH1A1HPGDKDM4ERAB9A
SCHEMBL27879248 0.72 SMN1; SMN2 (0.61) NPC1ALDH1A1HPGDRAB9AKMT2A
SCHEMBL30842121 0.71 KDM4E (0.53) NPC1ALDH1A1HPGDKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-11911372-B2 Compounds CTXT PTY LTD (AU) 2024-02-27 US disclosed
US-20210213004-A1 Compounds CTXT PTY LTD (AU) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210213004-A1 Compounds SLC10A1, ABCB11, REN NPC1 13/4885ALDH1A1 744/4885HPGD 1882/4885
US-11911372-B2 Compounds SLC10A1, ABCB11, REN NPC1 13/4885ALDH1A1 744/4885HPGD 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.